It is relatively simple, $HIMS (+10,47%) should be judged as a rapidly growing telemedicine platform that enables healthcare delivery in the most convenient and compelling way.
$HIMS (+10,47%) GLP1 was already growing strongly before GLP1 and will, in my opinion, continue to develop and expand as one of the largest and leading telemedicine platforms.
A platform and brand designed to provide affordable access to medical care and products.
A personalized medical companion with tailored treatments for every need.
A vertically integrated, AI-powered platform with in-house compounding and testing.
You should tune out the short-term noise and wear noise protection if necessary 😁, the long-term potential and adoption of the platform and products is undeniable.
This graphic illustrates this very well:
